4-Bromomethyl-2-hydroxy-benzoic acid | 210174-43-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-Bromomethyl-2-hydroxy-benzoic acid
• 英文别名: 4-(Bromomethyl)-2-hydroxybenzoic acid
• CAS: 210174-43-9
• 化学式: C₈H₇BrO₃
• 分子量: 231.046
• InChiKey: CCVFEAWPAQGCCI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  12
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  57.5
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-Bromomethyl-2-hydroxy-benzoic acid 在 盐酸 作用下， 以 水 为溶剂， 反应 75.0h， 生成 2-Hydroxy-4-phosphonomethyl-benzoic acid
  参考文献：
  名称：

  Garuti; Ferranti; Ronerti, Pharmazie, 1992, vol. 47, # 4, p. 295 - 297

  摘要：

  DOI：
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 N-溴代丁二酰亚胺(NBS) 、 过氧化氢苯甲酰 作用下， 以 四氯化碳 为溶剂， 反应 3.0h， 生成 4-Bromomethyl-2-hydroxy-benzoic acid
  参考文献：
  名称：

  Garuti; Ferranti; Ronerti, Pharmazie, 1992, vol. 47, # 4, p. 295 - 297

  摘要：

  DOI：

文献信息

• Heterosupramolecular Chemistry: Synthetic strategies for the covalent and noncovalent assembly and organization of nanocrystals and molecules
  作者：S. Nagarajo Rao、Donald Fitzmaurice

  DOI：10.1002/hlca.19980810511

  日期：——

  Described are the preparation of nanocrystals and the synthesis of molecules that may be covalently or noncovalently assembled in solution to yield heterosupermolecules possessing a well-defined heterosupramolecular function. Also described are preparative and synthetic methods that yield organized assemblies of heterosupermolecules possessing an addressable heterosupramolecular function. Finally, the development

  描述了纳米晶体的制备和可以在溶液中共价或非共价组装的分子的合成，以产生具有明确定义的杂超分子功能的杂超分子。还描述了制备和合成方法，其产生具有可寻址的异超分子功能的杂化超分子的有组织的组装。最后，概述了这些合成策略的发展，以允许共价和非共价组装和组织多种缩合相和分子组分。
• [EN] TRICYCLIC DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM<br/>[FR] DERIVES TRICYCLIQUES OU SELS PHARMACEUTIQUEMENT ACCEPTABLES DE CES DERIVES, LEURS PREPARATIONS ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT
  申请人：JE IL PHARMACEUTICAL CO LTD

  公开号：WO2004113281A1

  公开（公告）日：2004-12-29

  The present invention relates to tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. More precisely, the present invention relates to tricyclic derivatives as colchicine derivatives, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. Tricyclic derivatives of the present invention show very powerful cytotoxicity to cancer cell lines but were much less toxic than colchicine or taxol, confirmed through animal toxicity test. Tricyclic derivatives of the invention also decrease the volume and weight of a tumor and have a strong angiogenesis inhibiting activity in HUVEC cells. Thus, tricyclic derivatives of the present invention can effectively be used as an anticancer agent, anti-proliferation agent and an angiogenesis inhibitor.

  本发明涉及三环衍生物或其药用盐，其制备以及含有它们的药物组合物。更准确地说，本发明涉及三环衍生物作为秋水仙碱衍生物，其药用盐，其制备以及含有它们的药物组合物。本发明的三环衍生物对癌细胞系表现出非常强大的细胞毒性，但比秋水仙碱或紫杉醇毒性要小得多，经动物毒性试验证实。本发明的三环衍生物还可以减小肿瘤的体积和重量，并且在HUVEC细胞中具有强大的抑制血管生成活性。因此，本发明的三环衍生物可以有效地用作抗癌剂、抗增殖剂和血管生成抑制剂。
• Tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them
  申请人：Kim Myung-Hwa

  公开号：US20070179143A1

  公开（公告）日：2007-08-02

  The present invention relates to tricyclic derivatives or pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. More precisely, the present invention relates to tricyclic derivatives as colchicine derivatives, pharmaceutically acceptable salts thereof, their preparations and pharmaceutical compositions containing them. Tricyclic derivatives of the present invention show very powerful cytotoxicity to cancer cell lines but were much less toxic than colchicine or taxol, confirmed through animal toxicity test. Tricyclic derivatives of the invention also decrease the volume and weight of a tumor and have a strong angiogenesis inhibiting activity in HUVEC cells. Thus, tricyclic derivatives of the present invention can effectively be used as an anticancer agent, anti-proliferation agent and an angiogenesis inhibitor.

  本发明涉及三环衍生物或其药学上可接受的盐、它们的制备方法以及含有它们的制药组合物。更具体地说，本发明涉及三环衍生物作为秋水仙素衍生物，药学上可接受的盐、它们的制备方法以及含有它们的制药组合物。本发明的三环衍生物对癌细胞株表现出非常强大的细胞毒性，但毒性比秋水仙素或紫杉醇要小得多，经动物毒性测试证实。本发明的三环衍生物还可以减少肿瘤的体积和重量，并在HUVEC细胞中表现出强大的抑制血管生成的活性。因此，本发明的三环衍生物可以有效地用作抗癌剂、抗增殖剂和抑制血管生成剂。
• BENZOYL PIPERIDINES/PYRROLIDINES FOR ENHANCING SYNAPTIC RESPONSE
  申请人：CORTEX PHARMACEUTICALS, INC.

  公开号：EP0839134A1

  公开（公告）日：1998-05-06
• TRICYCLIC DERIVATIVES OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
  申请人：JE IL Pharmaceutical Co., Ltd.

  公开号：EP1646608A1

  公开（公告）日：2006-04-19